vs
Concord Medical Services Holdings Ltd（CCM）与湘南美容医疗集团（SBC）财务数据对比。点击上方公司名可切换其他公司
泰和诚医疗控股有限公司是中国领先的肿瘤医疗服务企业，主营放射治疗、医学影像诊断服务，运营多家肿瘤诊疗中心，与各级公立及私立医疗机构合作提供专业诊疗服务，同时配套提供医疗设备管理解决方案。
湘南美容医疗集团是总部位于日本的知名医疗服务提供商，核心业务覆盖美容整形、皮肤科诊疗、抗衰老健康护理等领域，在日本各地运营大量连锁诊所，同时服务本地居民及赴日就医的国际游客。
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收
CCM
SBC
| Q4 25 | — | $39.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $43.4M | ||
| Q1 25 | — | $47.3M | ||
| Q4 24 | — | $44.4M | ||
| Q3 24 | — | $53.1M | ||
| Q2 24 | — | $53.1M | ||
| Q1 24 | — | $54.8M |
净利润CCMSBC
| Q4 25 | — | $14.2M | ||
| Q3 25 | — | $12.8M | ||
| Q2 25 | — | $2.5M | ||
| Q1 25 | — | $21.5M | ||
| Q4 24 | — | $6.5M | ||
| Q3 24 | — | $2.8M | ||
| Q2 24 | — | $18.5M | ||
| Q1 24 | — | $18.8M |
毛利率CCMSBC
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.1% |
营业利润率CCMSBC
| Q4 25 | — | 32.5% | ||
| Q3 25 | — | 36.6% | ||
| Q2 25 | — | 33.6% | ||
| Q1 25 | — | 51.1% | ||
| Q4 24 | — | 10.6% | ||
| Q3 24 | — | 26.1% | ||
| Q2 24 | — | 51.4% | ||
| Q1 24 | — | 44.6% |
净利率CCMSBC
| Q4 25 | — | 35.9% | ||
| Q3 25 | — | 29.6% | ||
| Q2 25 | — | 5.7% | ||
| Q1 25 | — | 45.4% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 5.3% | ||
| Q2 24 | — | 34.8% | ||
| Q1 24 | — | 34.2% |
每股收益（稀释后）CCMSBC
| Q4 25 | — | $0.15 | ||
| Q3 25 | — | $0.12 | ||
| Q2 25 | — | $0.02 | ||
| Q1 25 | — | $0.21 | ||
| Q4 24 | — | $0.05 | ||
| Q3 24 | — | $0.03 | ||
| Q2 24 | — | $0.20 | ||
| Q1 24 | — | $0.20 |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
